1.Jung K-W, Won Y-J, Kong H-J, Lee ES: Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Research and Treatment: Official Journal of Korean Cancer Association 2018, 50(2):303.
2.Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A: Cancer treatment and survivorship statistics, 2016. CA: a cancer journal for clinicians 2016, 66(4):271–289.
3.Ceelen W, Pattyn P, Mareel M: Surgery, wound healing, and metastasis: recent insights and clinical implications. Critical reviews in oncology/hematology 2014, 89(1):16–26.
4.Xu Y, Li S, Cheng Q, Chen W, Wang S, Ren Y, Miao C: Effects of anaesthesia on proliferation, invasion and apoptosis of LoVo colon cancer cells in vitro. Anaesthesia 2016, 71(2):147–154.
5.Vogelaar FJ, Lips DJ, van Dorsten FR, Lemmens VE, Bosscha K: Impact of anaesthetic technique on survival in colon cancer: a review of the literature. Gastroenterology report 2015, 4(1):30–34.
6.Li R, Liu H, Dilger JP, Lin J: Effect of Propofol on breast Cancer cell, the immune system, and patient outcome. BMC anesthesiology 2018, 18(1):77.
7.Wigmore TJ, Mohammed K, Jhanji S: Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer SurgeryA Retrospective Analysis. Anesthesiology: The Journal of the American Society of Anesthesiologists 2016, 124(1):69–79.
8.Dong Kyu L: An introduction to propensity score matching methods. Anesth Pain Med 2016, 11(2):130–148.
9.Stevens RA, Chester WL, Artuso JD, Bray JG, Nellestein JA: Back pain after epidural anesthesia with chloroprocaine in volunteers: preliminary report. Reg Anesth 1991, 16(4):199–203.
10.Luo X, Zhao H, Hennah L, Ning J, Liu J, Tu H, Ma D: Impact of isoflurane on malignant capability of ovarian cancer in vitro. British journal of anaesthesia 2015, 114(5):831–839.
11.Rohwer N, Lobitz S, Daskalow K, Jons T, Vieth M, Schlag PM, Kemmner W, Wiedenmann B, Cramer T, Hocker M: HIF–1alpha determines the metastatic potential of gastric cancer cells. British journal of cancer 2009, 100(5):772–781.
12.Buckley A, McQuaid S, Johnson P, Buggy DJ: Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study. British journal of anaesthesia 2014, 113 Suppl 1:i56–62.
13.Huang H, Benzonana LL, Zhao H, Watts HR, Perry NJ, Bevan C, Brown R, Ma D: Prostate cancer cell malignancy via modulation of HIF–1alpha pathway with isoflurane and propofol alone and in combination. British journal of cancer 2014, 111(7):1338–1349.
14.Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S: Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesthesia and analgesia 2003, 97(5):1331–1339.
15.Ke JJ, Zhan J, Feng XB, Wu Y, Rao Y, Wang YL: A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesthesia and intensive care 2008, 36(1):74–78.
16.Dubowitz JA, Sloan EK, Riedel BJ: Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis. Clinical & experimental metastasis 2018, 35(4):347–358.
17.Enlund M, Berglund A, Andreasson K, Cicek C, Enlund A, Bergkvist L: The choice of anaesthetic—sevoflurane or propofol—and outcome from cancer surgery: a retrospective analysis. Upsala journal of medical sciences 2014, 119(3):251–261.
18.Soltanizadeh S, Degett TH, Gogenur I: Outcomes of cancer surgery after inhalational and intravenous anesthesia: A systematic review. Journal of clinical anesthesia 2017, 42:19–25.
19.Jun IJ, Jo JY, Kim JI, Chin JH, Kim WJ, Kim HR, Lee EH, Choi IC: Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: A retrospective observational study. Scientific reports 2017, 7(1):14020.
20.Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B: Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Canadian journal of anaesthesia = Journal canadien d’anesthesie 2019, 66(5):546–561.
21.Lim A, Braat S, Hiller J, Riedel B: Inhalational versus propofol-based total intravenous anaesthesia: practice patterns and perspectives among Australasian anaesthetists. Anaesthesia and intensive care 2018, 46(5):480–487.
22.Yoo S, Lee HB, Han W, Noh DY, Park SK, Kim WH, Kim JT: Total Intravenous Anesthesia versus Inhalation Anesthesia for Breast Cancer Surgery: A Retrospective Cohort Study. Anesthesiology 2019, 130(1):31–40.
23.Yan T, Zhang GH, Wang BN, Sun L, Zheng H: Effects of propofol/remifentanil-based total intravenous anesthesia versus sevoflurane-based inhalational anesthesia on the release of VEGF-C and TGF-beta and prognosis after breast cancer surgery: a prospective, randomized and controlled study. BMC anesthesiology 2018, 18(1):131.
24.Minlikeeva AN, Freudenheim JL, Cannioto RA, Szender JB, Eng KH, Modugno F, Ness RB, LaMonte MJ, Friel G, Segal BH et al: History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. Cancer causes & control: CCC 2017, 28(5):469–486.
25.Yang L, Zhu H, Liu D, Liang S, Xu H, Chen J, Wang X, Xu Z: Aspirin suppresses growth of human gastric carcinoma cell by inhibiting survivin expression. J Biomed Res 2011, 25(4):246–253.
26.Ma Z, Wang W, Jin G, Chu P, Li H: Effect of statins on gastric cancer incidence: a meta-analysis of case control studies. Journal of cancer research and therapeutics 2014, 10(4):859–865.
27.Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M: Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet (London, England) 2017, 389(10076):1323–1335.